🔗 Share this article

The Nobel Prize in medical science was awarded for revolutionary findings that clarify how the immune system targets dangerous infections while protecting the body's own cells.

Three renowned researchers—Japan's Prof. Sakaguchi and American scientists Dr. Brunkow and Fred Ramsdell—received this accolade.

The research identified unique "security guards" within the defense system that remove rogue immune cells that could harming the body.

The discoveries are now enabling new therapies for autoimmune diseases and cancer.

The laureates will share a prize fund worth 11 million SEK.

Decisive Findings

"The research has been essential for comprehending how the body's defenses functions and why we do not all develop severe self-attack conditions," stated the chair of the award panel.

The trio's research explain a fundamental mystery: How does the defense system protect us from numerous infections while leaving our own tissues intact?

The body's protection system employs immune cells that search for indicators of disease, including viruses and germs it has not met before.

Such defenders employ detectors—called recognition units—that are produced randomly in countless combinations.

That provides the defense network the capacity to combat a broad range of threats, but the unpredictability of the process unavoidably produces immune cells that can target the body.

Protectors of the Immune System

Researchers earlier knew that a portion of these problematic white blood cells were destroyed in the thymus—the site where white blood cells develop.

The latest Nobel Prize recognizes the discovery of regulatory T-cells—known as the immune system's "peacekeepers"—which patrol the body to neutralize any immune cells that attack the healthy cells.

It is known that this mechanism fails in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.

The prize committee stated, "These findings have established a novel area of investigation and accelerated the creation of innovative therapies, for instance for tumors and autoimmune diseases."

In malignancies, T-regs block the body from fighting the growth, so studies are focused on lowering their quantity.

For autoimmune diseases, trials are testing boosting regulatory T-cells so the organism is not being harmed. A similar method could also be useful in reducing the risks of organ transplant failure.

Pioneering Experiments

Professor Sakaguchi, from Osaka University, performed tests on mice that had their thymus removed, causing self-attack conditions.

The researcher showed that introducing defense cells from other animals could prevent the illness—implying there was a mechanism for blocking immune cells from attacking the host.

Mary Brunkow, affiliated with the a research center in Seattle, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in a California city, were investigating an inherited autoimmune disease in rodents and humans that led to the discovery of a genetic factor vital for the way T-regs function.

"Their groundbreaking work has uncovered how the body's defenses is kept in check by T-reg cells, stopping it from mistakenly targeting the body's own tissues," commented a leading biological science specialist.

"This research is a striking illustration of how basic biological research can have far-reaching implications for human health."